| 27.84 0.9 (3.34%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 33.03 |
1-year : | 38.58 |
| Resists | First : | 28.28 |
Second : | 33.03 |
| Pivot price | 26.19 |
|||
| Supports | First : | 25.74 |
Second : | 24.17 |
| MAs | MA(5) : | 27.21 |
MA(20) : | 26.07 |
| MA(100) : | 24.76 |
MA(250) : | 21.6 |
|
| MACD | MACD : | 0.2 |
Signal : | 0 |
| %K %D | K(14,3) : | 84  |
D(3) : | 84.7 |
| RSI | RSI(14): 60.8 |
|||
| 52-week | High : | 30.42 | Low : | 14.72 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ NVST ] has closed below upper band by 8.1%. Bollinger Bands are 0.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 28.29 - 28.43 | 28.43 - 28.57 |
| Low: | 27.02 - 27.16 | 27.16 - 27.31 |
| Close: | 27.61 - 27.84 | 27.84 - 28.07 |
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Thu, 16 Apr 2026
This dental curing light adds 360° access and built-in output checks - Stock Titan
Thu, 16 Apr 2026
Citi Maintains Envista Holdings(NVST.US) With Hold Rating, Maintains Target Price $29 - Moomoo
Thu, 16 Apr 2026
Citigroup initiates coverage of Envista Holdings (NVST) with neutral recommendation - MSN
Wed, 15 Apr 2026
NVST Initiated by Citigroup -- Price Target Announced at $29.00 - GuruFocus
Wed, 08 Apr 2026
Envista Schedules First Quarter 2026 Earnings Call - Morningstar
Wed, 08 Apr 2026
Envista to post Q1 results May 6, with webcast at 2 p.m. PT - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Equipment & Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 164 (M) |
| Held by Insiders | 1.6318e+008 (%) |
| Held by Institutions | 0.5 (%) |
| Shares Short | 7,970 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0.28 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 146.1 |
| Profit Margin | 1.7 % |
| Operating Margin | 10.7 % |
| Return on Assets (ttm) | 2.7 % |
| Return on Equity (ttm) | 1.5 % |
| Qtrly Rev. Growth | 15 % |
| Gross Profit (p.s.) | 1.57895e+009 |
| Sales Per Share | 2.86316e+009 |
| EBITDA (p.s.) | 3.80526e+008 |
| Qtrly Earnings Growth | 3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 276 (M) |
| PE Ratio | 99.42 |
| PEG Ratio | 0 |
| Price to Book value | 0.19 |
| Price to Sales | 0 |
| Price to Cash Flow | 1.39 |
| Dividend | 0 |
| Forward Dividend | 7.3e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|